Patent details

Basic Information

Publication number:

EP1397156

PCT Application Number:

PCT/EP/2002/006017

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027509975

PCT Publication Number:

WO/2002/098453

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL ADMINISTRATION OF PARATHYROID HORMONE AND CALCITONIN

French Title of Invention:

METHODE D'ADMINISTRATION ORALE D'UNE HORMONE PARATHYROIDE (PTH)

German Title of Invention:

ORALE VERABREICHUNG VON PARATHYROIDHORMON UND CALCITONIN

SPC Number:

Dates

Filing date:

31/05/2002

Grant date:

14/03/2007

EP Publication Date:

14/03/2007

PCT Publication Date:

12/12/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/03/2004

EP B1 Publication Date:

14/03/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/05/2007

Expiration date:

31/05/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/05/2002

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

BATEMAN Simon, David

Address:

United States (US)

2

Name:

AULT Joseph, M.

Address:

United States (US)

3

Name:

McLEOD James, F.

Address:

United States (US)

4

Name:

AZRIA Moise

Address:

Switzerland (CH)

Priority

Priority Number:

295169 P

Priority Date:

01/06/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/29;